Personal Therapy Assistant feature for AirSense 11 users, seen here within the myAir app SAN DIEGO, Aug. 16, 2021 (GLOBE NEWSWIRE) -- ResMed, a global leader in digital health and sleep apnea ...
ResMed Inc. RMD recently launched AirSense 11, the company’s next-generation PAP (positive airway pressure) device. AirSense 11 is available in the United States, with other countries to follow, and ...
Sleep apnea has become a global health concern, affecting millions of people and leading to fatigue, cardiovascular disease, and other chronic health issues. To address this widespread problem, ResMed ...
CEO Michael Farrell reported 10% global revenue growth, driven by demand across the sleep health, breathing health, and residential care software portfolios. Device sales, including AirSense 10 and ...
O2Xpress is excited to announce the addition of the state-of-the-art ResMed AirSense 11 AutoSet to its extensive range of premium sleep therapy solutions. Engineered by global healthcare leader ResMed ...
SAN DIEGO, Aug. 16, 2021 (GLOBE NEWSWIRE) -- ResMed, a global leader in digital health and sleep apnea treatment, (NYSE: RMD, ASX: RMD) today launched AirSense 11, available first in the U.S., the ...
ResMed Inc. RMD recently launched AirSense 11, the company’s next-generation PAP (positive airway pressure) device. AirSense 11 is available in the United States, with other countries to follow, and ...
SAN DIEGO, Aug. 16, 2021 (GLOBE NEWSWIRE) -- ResMed, a global leader in digital health and sleep apnea treatment, (NYSE: RMD, ASX: RMD) today launched AirSense 11, available first in the U.S., the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback